Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019

Clinical trial NCT01797965 · TERMINATED

Trial details

NCT number

NCT01797965

Sponsor

Biogen

Status

TERMINATED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2013-02-15

Primary completion

2018-09-24

Enrollment

1501

View on ClinicalTrials.gov